Researcher
Hans Deckmyn
- Disciplines:Biochemistry and metabolism, Cardiac and vascular medicine, Medical biochemistry and metabolism
Affiliations
- Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Jan 2009 → Today - Faculty of Science, Kulak Kortrijk Campus (Faculty)
Member
From1 Oct 1999 → 31 Dec 2008
Projects
1 - 10 of 20
- TRANSUNIV: University education and professional integration.From1 Jan 2018 → 31 Mar 2021Funding: Other EU initiatives out of framework
- Mouse housing and micorscopy platform for cardiovascular and antibody-based researchFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Bacteriophages and monolith-cryogels: A new robust tool in chromatographyFrom1 Oct 2016 → 30 Sep 2018Funding: IOF - Industrial Research Fund
- Targeted nanoparticles for combined multimodal imaging and therapy: NanoCoMIT.From1 Jan 2015 → 31 Dec 2018Funding: SBO (Strategic basic research)
- Evaluation of p53 aggregation as a drug target in oncology.From1 Nov 2014 → 31 Oct 2018Funding: SBO (Strategic basic research)
- Bloedplaatjes CD40 co-stimulatie: een sterke leukocyt en endotheel activator in vasculaire inflammatie.From1 Oct 2013 → 28 Feb 2014Funding: FWO fellowships
- Investigation of the role of GARP by using cell specific knockout miceFrom1 Oct 2013 → 12 Sep 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unravelling the role of ADAMTS13 and anti-ADAMTS13 autoantibodies in the pathophysiology of thrombotic thrombocytopenic purpuraFrom1 Oct 2013 → 14 May 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- PLATELET CD40-CD40L COSTIMULATION AS A PROTAGONIST OF VASCULAR INFLAMMATION.From1 Jan 2013 → 31 Dec 2013Funding: FWO Pegasus Marie Curie Fellowships
- The function of LRRC32 in thrombosis, haemostasis and regulatory T cell homeostasisFrom1 Jan 2013 → 31 Dec 2016Funding: FWO research project
Publications
21 - 30 of 128
- Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.(2018)
Authors: Elien Roose, Kadri Kangro, An-Sofie Schelpe, Daan Dierickx, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 1729 - 1742 - Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors(2018)
Authors: Elien Vermeersch, Conny Gysemans, Karen Vanhoorelbeke, Simon De Meyer, Wim Maes, Hans Deckmyn
Pages: 129 - 133 - Investigation of the role of GARP by using cell specific knockout mice(2018)
Authors: Elien Vermeersch, Hans Deckmyn, Claudia Tersteeg, Wim Maes
- Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation(2018)
Authors: Karen Vanhoorelbeke, Hans Deckmyn
Pages: 1397 - 1408 - Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome(2018)
Authors: S Deconinck, C Terseeg, E Bailleul, L Delrue, N Vandeputte, Hans Deckmyn, S De Meyer, K Vanhoorelbeke, M Vanderheyden
Pages: 1067 - 1067 - Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans(2018)
Authors: Hans Deckmyn
Pages: 2605 - 2616 - Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13(2018)
Authors: An-Sofie Schelpe, Elien Roose, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 1 - 9 - An open conformation of ADAMTS13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura(2018)
Authors: Elien Roose, An-Sofie Schelpe, Marijke Peetermans, Peter Verhamme, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 378 - 388 - High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease(2017)
Authors: Irina Portier, Karen Vanhoorelbeke, Hans Deckmyn, Simon De Meyer
Pages: 592 - 604 - Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets(2017)
Authors: Simon De Meyer, Hans Deckmyn
Pages: 787 - 796